Publications

Xia, M; Hoq, MR; Huang, P; Jiang, W; Jiang, X; Tan, M. Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity. Nano Research. 2022; 15:4181-4190.

Ison, MG; Tan, M; Daud, A; Huang, P; Jiang, JX. Quantitative norovirus viral load is not affected by home storage of stool. Transplant Infectious Disease. 2022.

Tan, M. Norovirus Vaccines: Current Clinical Development and Challenges. Pathogens. 2021; 10.

Jiang, X; Tan, M; Xia, M; Huang, P; Kennedy, MA. Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics?. Emerging Microbes and Infections. 2021; 10:1191-1199.

Xu, S; McGinnis, KR; Liu, Y; Huang, P; Tan, M; Stuckert, MR; Burnside, RE; Jacob, EG; Ni, S; Jiang, X; et al. Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens. Proceedings of the National Academy of Sciences of the United States of America. 2021; 118.

Zhou, HL; Chen, LN; Wang, SM; Tan, M; Qiu, C; Qiu, TY; Wang, XY. Prevalence and Evolution of Noroviruses between 1966 and 2019, Implications for Vaccine Design. Pathogens. 2021; 10.

Xue, Z; Han, Q; Huang, P; Jiang, X; Tan, M; Zhao, Y; Li, N; Zhang, R. Characterization of Functional Components in Bovine Colostrum That Inhibit Norovirus Capsid Protruding Domains Interacting with HBGA Ligands. Pathogens. 2021; 10.

Wang, JX; Chen, LN; Zhang, CJ; Zhou, HL; Zhang, YH; Zhang, XJ; Hao, ZY; Qiu, C; Ma, JC; Zhao, YL; et al. Genetic susceptibility to rotavirus infection in Chinese children: a population-based case-control study. Human Vaccines and Immunotherapeutics. 2021; 17:1803-1810.

Liu, C; Huang, P; Zhao, D; Xia, M; Zhong, W; Jiang, X; Tan, M. Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine. Vaccine. 2021; 39:263-271.

Xia, M; Huang, P; Jiang, X; Tan, M. A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses. Viruses. 2021; 13.

Zhang, XF; Chen, JR; Song, CL; Xie, DJ; Tan, M; Wang, L; Koroma, MM; Hou, YZ; Dong, ZP; Yu, JR; et al. Characterization of a hospital-based gastroenteritis outbreak caused by GII.6 norovirus in Jinshan, China. Epidemiology and Infection. 2020; 148.

Zhao, D; Liu, Y; Huang, P; Xia, M; Li, W; Tan, M; Zhang, X; Jiang, X. Histo-blood group antigens as divergent factors of groups A and C rotaviruses circulating in humans and different animal species. Emerging Microbes and Infections. 2020; 9:1609-1617.

Guo, L; Zhang, M; Hou, Y; Hu, H; Fang, L; Tan, M; Huang, Q; Li, H; Sun, L; Jiang, X; et al. Epidemiology and HBGA-susceptibility investigation of a G9P[8] rotavirus outbreak in a school in Lechang, China. Archives of Virology. 2020; 165:1311-1320.

Sun, X; Dang, L; Li, D; Qi, J; Wang, M; Chai, W; Zhang, Q; Wang, H; Bai, R; Tan, M; et al. Structural Basis of Glycan Recognition in Globally Predominant Human P[8] Rotavirus. Virologica Sinica. 2020; 35:156-170.

Xu, S; Ahmed, LU; Stuckert, MR; McGinnis, KR; Liu, Y; Tan, M; Huang, P; Zhong, W; Zhao, D; Jiang, X; et al. Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens. PLoS Pathogens. 2020; 16.

Ramesh, A; Mao, J; Lei, S; Twitchell, E; Shiraz, A; Jiang, X; Tan, M; Yuan, L. Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs. Vaccines. 2019; 7.

Zhou, H; Tan, M; Wang, X. Pathogenesis and diagnosis of norovirus. 2019; 14:303-309.

Tan, M; Jiang, X. Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development. Pharmaceutics. 2019; 11.

Cong, X; Sun, X; Qi, J; Li, H; Chai, W; Zhang, Q; Wang, H; Kong, X; Song, J; Pang, L; et al. GII.13/21 Noroviruses Recognize Glycans with a Terminal β-Galactose via an Unconventional Glycan Binding Site. Journal of Virology. 2019; 93.

Xia, M; Huang, P; Jiang, X; Tan, M. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice. Vaccine. 2019; 37:4103-4110.

Qian, Y; Song, M; Jiang, X; Xia, M; Meller, J; Tan, M; Chen, Y; Li, X; Rao, Z. Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths. Journal of Virology. 2019; 93.

Yang, Y; Xia, M; Wang, L; Arumugam, S; Wang, Y; Ou, X; Wang, C; Jiang, X; Tan, M; Chen, Y; et al. Structural basis of host ligand specificity change of GII porcine noroviruses from their closely related GII human noroviruses. Emerging Microbes and Infections. 2019; 8:1642-1657.

Tan, M; Cui, L; Huo, X; Xia, M; Shi, F; Zeng, X; Huang, P; Zhong, W; Li, W; Xu, K; et al. Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection. Emerging Microbes and Infections. 2018; 7.

Xia, M; Huang, P; Sun, C; Han, L; Vago, FS; Li, K; Zhong, W; Jiang, W; Klassen, JS; Jiang, X; et al. Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform. ACS Nano. 2018; 12:10665-10682.

Han, L; Zheng, R; Richards, MR; Tan, M; Kitova, EN; Jiang, X; Klassen, JS. Quantifying the binding stoichiometry and affinity of histo-blood group antigen oligosaccharides for human noroviruses. Glycobiology. 2018; 28:488-498.

Ao, Y; Cong, X; Jin, M; Sun, X; Wei, X; Wang, J; Zhang, Q; Song, J; Yu, J; Cui, J; et al. Genetic Analysis of Reemerging GII.P16-GII.2 Noroviruses in 2016-2017 in China. Journal of Infectious Diseases. 2018; 218:133-143.

Sun, X; Wang, L; Qi, J; Li, D; Wang, M; Cong, X; Peng, R; Chai, W; Zhang, Q; Wang, H; et al. Human Group C Rotavirus VP8*s Recognize Type A Histo-Blood Group Antigens as Ligands. Journal of Virology. 2018; 92.

Opriessnig, T; Gauger, PC; Gerber, PF; Castro, AM M G; Shen, H; Murphy, L; Digard, P; Halbur, PG; Xia, M; Jiang, X; et al. Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model. PLoS ONE. 2018; 13.